Action of morphine on the blood sugar level had previously been described in the voluminous literatures and the mechanism of hyperglycemic action had widely been known to be a central stimulation in the posterial hypothalamus, to increase adrenal epinephrine secretion (l-4). E. Larson (5) reported that methadone, dromoran and meperidine produced hyperglycemia in rabbits and rats. He, however, had mentioned in the same report that not a few rats, which were administered with 25-50 mg/kg of morphine in his experiment, died under hypoglycemia.<BR>
The action mode of hypoglycemia produced by morphine had never been investigated, since the studies on this action was found very difficult on account of overlapping with hyperglycemic response in animals produced by morphine itself. It is consequent that the morphine-derivatives showing purely hypoglycemic effect without any hyperglycemic re sponses is expected to be synthetized as an experimental materials. 4-Dimethylamino-n methyl-2,2-diphenyl valeramide hydrochloride (U-6420), which's chemical structure was related with that of methadone, was reported as a hypoglycemic agent by Dulin et al. (6) and was recently found to have an additive effect on morphine-hypoglycemia (7) . It seemed expectable that if the compound mentioned above would have the similar action-mechanism to the morphine's one, some active compounds might be discovered in the group of derivatives from methadone, since these reports told us that the toxic dose (respiration arrest) of U-6420 was near to its effective level.<BR> Present communication described the results of screening test for 3 and/or 4 substi tutes of N-methyl piperidines and the actions of the derivatives of 3-aza bicyclo 3, 3, 1 nonane screened by our experiments.
METHODS AND MATERIALS
Derivatives of N-methyl piperidines were screened by the method based on hypoglycemic response in the Donryu strain rats. The animals were kept with the special diet (high protein, high fat diet) and were maintained in the high temperature room. The details of experimental procedures were reported previously (8) .
In the observation on the antagonism to morphine hyperglycemia, a derivative of 3-aza bicyclo nonane was orally administered at one hour before the test carried out in the similar way to the rat's hypoglycemia method described above.
The intravenous glucose tolerance test in rabbits was carried out by the single admini stration method reported by Takeuchi et al. (9) .
The drugs tested were generally administered into stomach of animals through the gastric tube, except for morphine hydrochloride, after dissolving to 5 % by physiological saline solution. 
RESULTS
The results of the screening test based on the rat's hypoglycemia response were sum marized in Tables 1, 2 and 3. As shown in Table 1 , any substances lowering the blood sugar level could not be found in the 4 or 2, 5-substitutes group and, rather, some of them, for example, 4-(3'-fluoro or 3'-trifluoromethyl)-phenyl compounds, were evidenced to show a weak hyperglycemic activity. Three compounds, on the other hand, were found to have a moderate hypoglycemic activity, in derivatives from 3-aza bicyclo nonane, which was regarded as a modification of 3, 5-substitute of N-methyl piperidine, as illustrated in Table 2 . 3, 7-Dimethyl-6-pyrrolidine-9-hydroxy 3-aza bicyclo 3, 3, 1 nonane (Y-3310) was evidenced to be most effective and less toxic among them (LD50, per os, = 500 mg/kg or more). The hypoglycemia in the rats administered orally with Y-3310 in a dose of 25 mg/kg or more continued during 1-3 hours following the administration, and it was found that the maximum response was 46% decrease in blood sugar level, this value being obtained from estimate at 3 hours after the administration of 500 mg/kg. The linear relation could be evidenced between the % decrease of the blood sugar level estimated at 2 hours after and the log-dose in a range from 25 mg/kg to 200 mg/kg (Fig. 1) .
It was found that the index e-k of the intravenous glucose tolerance curve in rabbits decreased significantly following the oral administration of 100 mg/kg of Y-3310, while the other index C was kept relatively constant. The shift-mode of the point on the e-" x C co-ordinate was illustrated in Fig. 2 . And the blood sugar levels at one hour after the Y-3310 administration in rabbits, that is, the estimates immediately before the injection of glucose, decreased non-significantly for the control levels. The results described above in dicated that the glucose assimilation ability increased and the regulation level of blood glucose was indifferent in rabbits, even after the Y-3310 administration. When Macleod had mentioned on antiglvicemic action of the opium alkaloids on the diabetic patients in 1914, the mode of this action was suggested to he an effect on alimentary canal, presumably by the gastric delay slowing the digestion and absorption of the carbo hydrates, and thus preventing the sudden flooding of the organism with sugar. Since then the opium alkaloids had never been recommended to use therapeutically in diabetic clinic This suggestion is well accepted by the present physicians, still it is not a negligible idea that the decrease of urinary sugar observed occationally in the patients treated with the opium alkaloids may partially be due to hypolgycemic effect of morphine. If the hypoglycemic principle would be extracted from the diphasic effect of morphine on the blood sugar, and 11 the principle possessing alone the blood sugar lowering action would well be tolerated without appearance of addiction, the studies on the control mechanism of the blood sugar level might powerfully be supported, since the hypoglycemia produced by morphine described as the delayed reaction by Larson (5) was reported to be additive with that of U-6420 (7), which's hypoglycemic action mode was evidenced to he decrease of hepatic glucose output induced by it's action on central nervous system (10) . But, U-6420 was an unsuitable drug for out studies, since appearance of the action of this compound was relatively slow and the animals in a critical stage by U-6420 hypoglycemia could not recover even after glucose injection on account of the respiration arrest.
The report by Hammouda and Samir Amer (11) on the action of tecomine and teco stamine seems to be suggestive to our work hypothesis, that there must be the substances, which decrease the blood sugar level by the action on central nervous system, in the group of the derivatives of N-methyl piperidine. It was doubtful whether Y-3310 screened in the present experiment was well fit for our intention or not?, still some informations suggesting the action mode of hypoglycemia were considered to be given in the present data. One of these data was found in the results of the intravenous glucose tolerance test in rabbits.
Changes of the two indicies, e_' decreasing and C being unchanged, seemed resemble with the effects of insulin infused continuously, but it, at the same time, was quite notable that they were different from the effects of U-6420. After administration of U-6420, both of two indicies did not show any changes as reported previously (12) . It was surely concluded that one of the mechanisms of Y-3310 might differ from that of U-6420, while it was not yet given a clear cut solution, whether Y-3310 accerelated the glucose uptake in the tissue, like insulin or not?
The results, on the other hand, of the antagonism test to morphine hyperglycemia told us a possibility that Y-3310 did not neutralize the morphine effect, but inhibited it. If Y-3310 would have any antimorphinic activities, they might be evidenced on wider spectrum of actions of morphine, that is, on analgesic, respiratory inhibiting, or smooth muscle spastic. The solution for these problems seems to be a pressing need to us, but it is necessary to note beforehand the difference in chemical structures between morphine and Y-3310, the former including one N atom and the latter including two atoms. The presence of OH at 9 position, of CH, at 7 and of pyrrolidine at 6 was apparently common to the active compounds drived from 3-aza bicyclo nonane.
It was interested that compounds became inactive when CH, at 7 position was translocated to 6 position, and the stimulating effect on central nervous system increased when phenyl radical was derived at 9 position. 6-Pyrrolidine was essential for its hypoglycemic activity, since 6-piperidine or 6-morpholine derivatives were found inactive. It is without saying that any active radicals adequating to pyrrolidine in Y-3310
can not be sought for in morphine or in U-6420. Furthermore, 3-aza bicyclo nonane, as supposed easily, must consist of several stereo-isomers, but it is not yet clear, which isomer is more active?
We are expecting to isolation of each isomer, since the mode of action of comers must differ from each other.
SUMMARY
Derivatives of N-methyl piperidine were screened by the rat's hypoglycemia test, and the derivatives of 3-aza bicyclo 3, 3, 1 nonane were found to have a moderate hypoglycemic activity. 3, 7-Dimethyl-6-pyrrolidine-9-hydroxy 3 aza bicyclo 3, 3, 1 nonane (Y-3310) was evidenced to be most active and less toxic among them. Y-3310 has an increasing activity of the glucose assimilation ability in rabbits and antagonizes to morphine hyperglycemia in rats.
